Dear Staff and Students,
We would like to share the following message from Department of Health about Updated information on Coronavirus Disease 2019 (COVID-19) and vaccines.
Health, Safety and Environment Office
Dear Staff and Students,
We would like to share the following message from Department of Health about Updated information on Coronavirus Disease 2019 (COVID-19) and vaccines.
Health, Safety and Environment Office
Updated information on Coronavirus Disease 2019 (COVID-19) and vaccines
1. Government to maintain most of the social distancing measures
Having observed the implementation of the second-phase measures under the 'vaccine bubble' , the Government maintains most of the social distancing measures currently in place while refining the measures applicable to places of amusement, places of public entertainment, sports premises and swimming pools.
For details, please refer to:
https://www.info.gov.hk/gia/general/202107/07/P2021070700799.htm
2. Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation assesses serious adverse events relating to COVID-19 vaccination
According to the World Health Organization, an Adverse Event Following Immunisation (AEFI) is any medical occurrence that follows immunisation and that does not necessarily have a causal relationship with the usage of the vaccine. The DH has put in place a pharmacovigilance system for COVID-19 immunisation, and is partnering with the University of Hong Kong to conduct an active surveillance programme for Adverse Events of Special Interest under the COVID-19 Vaccines Adverse Events Response and Evaluation Programme. The main purpose of the pharmacovigilance system is to detect potential signals of possible side effects of the vaccines.
As of June 30, a total of 11,928 persons had been infected with COVID-19 in Hong Kong, of which 211 had died of the disease. Separately, about 3.729 million doses of COVID-19 vaccines had been administered for members of the public in Hong Kong. Around 2.249 million people had received at least one vaccine dose. In the same period, the DH received about 4,010 reports of adverse events (0.11 per cent of total vaccine doses administered), including 23 death cases (Note) with vaccination within 14 days before they passed away (0.0006 per cent of total vaccine doses administered).
As at July 5, the Expert Committee had assessed the 23 death cases and concluded that 13 death cases had no causal relationship with vaccination, and preliminarily considered that 10 cases were not associated with vaccination. The Expert Committee considered there is no unusual pattern identified so far, and it will continue to closely monitor the situation and collect data for assessment.
For details, please refer to:
https://www.info.gov.hk/gia/general/202107/05/P2021070500809.htm
More information on COVID-19:
We would like to solicit your support to disseminate the information to your colleagues, work associates and/or business partners so that they could adopt proper preventive measures. Thank you very much for your support.
Department of Health
******************************************
敬啟者：
2019冠狀病毒病及疫苗的最新資訊
1. 政府維持大部分社交距離措施
經觀察『疫苗氣泡』第二階段措施的實施情況後，政府大致維持現行社交距離措施，並稍為調整適用於遊樂場所、公眾娛樂場所、體育處所及泳池的措施。
詳情可參閱：
https://www.info.gov.hk/gia/general/202107/07/P2021070700796.htm
2. 新冠疫苗臨床事件評估專家委員會評估有關接種新冠疫苗的嚴重異常事件
根據世界衞生組織，疫苗接種異常事件是指免疫接種後發生的任何醫療事件，不一定與疫苗使用有因果關係。衞生署建立了新冠疫苗藥物安全監測系統，亦與香港大學合作透過「2019冠狀病毒病疫苗安全監測計劃」主動監測新冠疫苗接種關注事件。藥物安全監測系統的主要目的是識別疫苗可能產生的副作用的潛在信號。
截至六月三十日，本港有11,928人感染2019冠狀病毒病，其中211人因感染該病而離世。另外，本港市民合共接種了約372.9萬劑新冠疫苗，已接種最少一劑疫苗的巿民約224.9萬名。同期，衞生署共接獲約4,010宗異常事件報告（佔疫苗接種總劑量的0.11%），當中包括23宗（註）涉及曾經於離世前14日內接種疫苗人士的死亡個案（佔疫苗接種總劑量的0.0006%）。
截至七月五日，專家委員會已評估該23宗死亡個案並總結13宗死亡個案與疫苗接種沒有因果關係，初步認為10宗個案與疫苗接種沒有關聯。專家委員會認為至今並未發現有不尋常的現象，會繼續密切監察有關情況並收集數據以作評估。
詳情可參閱：
https://www.info.gov.hk/gia/general/202107/05/P2021070500810.htm
更多2019冠狀病毒病資訊：
希望你可以將有關資訊與你的同事、合作者及／或業務伙伴分享，讓他們都能採取合適的預防措施。非常感謝你的支持。
衞生署
